{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T14:01:38Z","timestamp":1784815298704,"version":"3.55.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.taap.2026.117796","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:19:59Z","timestamp":1773361199000},"page":"117796","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Ezetimibe counteracts lipopolysaccharide-induced liver injury in mice via modulating TLR4-mediated MYD88\/TRAF-6\/NF-kB signaling pathway"],"prefix":"10.1016","volume":"511","author":[{"given":"Abeer G.","family":"Sakr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda E.","family":"Kafl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia H.","family":"El-Kashef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2026.117796_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109130","article-title":"Interleukin-6 cytokine: an overview of the immune regulation, immune dysregulation, and therapeutic approach","volume":"111","author":"Aliyu","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.taap.2026.117796_bb0010","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4103\/MJBL.MJBL_1510_23","article-title":"Hepatoprotective activity of ezetimibe against risperidone-induced liver injury in rats","volume":"21","author":"Al-Juhaishi","year":"2024","journal-title":"Med. J. Babyl."},{"issue":"4","key":"10.1016\/j.taap.2026.117796_bb0015","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.21037\/jtd.2019.04.14","article-title":"Effects of glycyrrhizin on lipopolysaccharide-induced acute lung injury in a mouse model","volume":"11","author":"Am Lee","year":"2019","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.taap.2026.117796_bb0020","article-title":"The effect of combination therapy with statins and ezetimibe on proinflammatory cytokines: a systematic review and meta-analysis of randomized controlled trials","volume":"113","author":"Arabi","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.taap.2026.117796_bb0025","article-title":"Baicalin alleviates LPS-induced oxidative stress via NF-\u03baB and Nrf2\u2013HO1 signaling pathways in IPEC-J2 cells","volume":"8","author":"Bao","year":"2022","journal-title":"Front. Veterin. Sci."},{"issue":"2","key":"10.1016\/j.taap.2026.117796_bb0030","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/jcp.25435","article-title":"LPS induces hyper-permeability of intestinal epithelial cells","volume":"232","author":"Bein","year":"2017","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.taap.2026.117796_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-6-9","article-title":"Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain","volume":"6","author":"Beurel","year":"2009","journal-title":"J. Neuroinflammation"},{"issue":"5","key":"10.1016\/j.taap.2026.117796_bb0040","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/JCMA.0000000000001075","article-title":"Ezetimibe treatment reduces oxidized low-density lipoprotein in biliary cirrhotic rats","volume":"87","author":"Chang","year":"2024","journal-title":"J. Chin. Med. Assoc."},{"issue":"1","key":"10.1016\/j.taap.2026.117796_bb0045","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/imr.12499","article-title":"The immune system\u2019s role in sepsis progression, resolution, and long-term outcome","volume":"274","author":"Delano","year":"2016","journal-title":"Immunol. Rev."},{"issue":"20","key":"10.1016\/j.taap.2026.117796_bb0050","doi-asserted-by":"crossref","first-page":"15767","DOI":"10.1021\/acs.chemrev.0c01321","article-title":"A journey from structure to function of bacterial lipopolysaccharides","volume":"122","author":"Di Lorenzo","year":"2021","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.taap.2026.117796_bb0055","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch. Biochem. Biophys."},{"issue":"5","key":"10.1016\/j.taap.2026.117796_bb0060","first-page":"196","article-title":"Therapeutic management of LDL-C: efficacy and economic impact assessment","volume":"12","author":"Elshafeey","year":"2025","journal-title":"J. Cardiovasc. Develop. Dis."},{"issue":"11","key":"10.1016\/j.taap.2026.117796_bb0065","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.taap.2026.117796_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175252","article-title":"Malvidin protects against lipopolysaccharide-induced acute liver injury in mice via regulating Nrf2 and NLRP3 pathways and suppressing apoptosis and autophagy","volume":"933","author":"Fan","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2026.117796_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12950-017-0150-y","article-title":"Ezetimibe reduces cholesterol content and NF-kappaB activation in liver but not in intestinal tissue in guinea pigs","volume":"14","author":"Fraunberger","year":"2017","journal-title":"J. Inflamm."},{"key":"10.1016\/j.taap.2026.117796_bb0080","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2147\/JIR.S306789","article-title":"Changes of lipopolysaccharide-induced acute kidney and liver injuries in rats based on metabolomics analysis","author":"Gao","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.taap.2026.117796_bb0085","article-title":"Sepsis: pathophysiology and clinical management","volume":"353","author":"Gotts","year":"2016","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.taap.2026.117796_bb0090","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/2040622316672544","article-title":"Ezetimibe: an update on its clinical usefulness in specific patient groups","volume":"8","author":"Hammersley","year":"2017","journal-title":"Therap. Adv. Chronic Dis."},{"key":"10.1016\/j.taap.2026.117796_bb0095","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s10753-015-0236-8","article-title":"TLR4-MyD88-TRAF6-TAK1 complex-mediated NF-\u03baB activation contribute to the anti-inflammatory effect of V8 in LPS-induced human cervical cancer SiHa cells","volume":"39","author":"He","year":"2016","journal-title":"Inflammation"},{"issue":"3","key":"10.1016\/j.taap.2026.117796_bb0100","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1128\/iai.64.3.1011-1015.1996","article-title":"Low-dose lipopolysaccharide (LPS) pretreatment of mouse macrophages modulates LPS-dependent interleukin-6 production in vitro","volume":"64","author":"Hirohashi","year":"1996","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.taap.2026.117796_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2016.45","article-title":"Sepsis and septic shock","volume":"2","author":"Hotchkiss","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.taap.2026.117796_bb0110","article-title":"Ezetimibe mitigates microglial activation in Parkinson\u2019s disease via TLR4\/JNK pathway inhibition: evidence from network pharmacology and experimental validation","volume":"1873","author":"Hua","year":"2025","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.taap.2026.117796_bb0115","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/157016111793744788","article-title":"Ezetimibe and vascular inflammation","volume":"9","author":"Ishibashi","year":"2011","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"17","key":"10.1016\/j.taap.2026.117796_bb0120","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1056\/NEJMsa0801461","article-title":"Use of ezetimibe in the United States and Canada","volume":"358","author":"Jackevicius","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.taap.2026.117796_bb0125","article-title":"Sophocarpine attenuates LPS-induced liver injury and improves survival of mice through suppressing oxidative stress, inflammation, and apoptosis","volume":"2018","author":"Jiang","year":"2018","journal-title":"Mediat. Inflamm."},{"issue":"9","key":"10.1016\/j.taap.2026.117796_bb0130","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/s41419-018-0838-9","article-title":"Overexpression of homeodomain-interacting protein kinase 2 (HIPK2) attenuates sepsis-mediated liver injury by restoring autophagy","volume":"9","author":"Jiang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.taap.2026.117796_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1468476","article-title":"Potential impact of ezetimibe on patients with NAFLD\/NASH: a meta-analysis of randomized controlled trials","volume":"15","author":"Jiao","year":"2024","journal-title":"Front. Endocrinol."},{"issue":"2","key":"10.1016\/j.taap.2026.117796_bb0140","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3904\/kjim.2019.043","article-title":"The utility of ezetimibe therapy in nonalcoholic fatty liver disease","volume":"34","author":"Jun","year":"2019","journal-title":"Korean J. Intern. Med."},{"issue":"3","key":"10.1016\/j.taap.2026.117796_bb0145","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4196\/kjpp.2013.17.3.209","article-title":"Protective effect of phosphatidylcholine on lipopolysaccharide-induced acute inflammation in multiple organ injury","volume":"17","author":"Jung","year":"2013","journal-title":"Korean J. Physiol. Pharmacol.: Off. J. Korean Physio. Soc. Korean Soc. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.taap.2026.117796_bb0150","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejphar.2010.02.003","article-title":"Pleiotropic effects of ezetimibe: do they really exist?","volume":"633","author":"Kalogirou","year":"2010","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.taap.2026.117796_bb0155","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1080\/15548627.2017.1356977","article-title":"Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition","volume":"13","author":"Kim","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.taap.2026.117796_bb0160","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11745-011-3539-z","article-title":"Ezetimibe treatment lowers indicators of oxidative stress in hypercholesterolemic subjects with high oxidative stress","volume":"46","author":"Kostapanos","year":"2011","journal-title":"Lipids"},{"issue":"4","key":"10.1016\/j.taap.2026.117796_bb0165","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/FJC.0b013e318211703b","article-title":"The effect of ezetimibe and simvastatin on monocyte cytokine release in patients with isolated hypercholesterolemia","volume":"57","author":"Krysiak","year":"2011","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"6","key":"10.1016\/j.taap.2026.117796_bb0170","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1002\/ptr.7471","article-title":"Paeoniflorin ameliorates lipopolysaccharide-induced acute liver injury by inhibiting oxidative stress and inflammation via SIRT1\/FOXO1a\/SOD2 signaling in rats","volume":"36","author":"Li","year":"2022","journal-title":"Phytother. Res."},{"issue":"1\u20133","key":"10.1016\/j.taap.2026.117796_bb0175","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ejphar.2008.06.047","article-title":"Human ApoA-I overexpression diminishes LPS-induced systemic inflammation and multiple organ damage in mice","volume":"590","author":"Li","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.taap.2026.117796_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.108110","article-title":"The physicochemical properties of lipopolysaccharide chemotypes regulate activation of the contact pathway of blood coagulation","volume":"301","author":"Lira","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2026.117796_bb0185","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s10620-006-9497-2","article-title":"Drug-induced liver injury associated with ezetimibe therapy","volume":"52","author":"Liu","year":"2007","journal-title":"Dig. Dis. Sci."},{"issue":"1","key":"10.1016\/j.taap.2026.117796_bb0190","first-page":"1","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.taap.2026.117796_bb0195","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.3892\/mmr.2017.7414","article-title":"Taurine alleviates lipopolysaccharide-induced liver injury by anti-inflammation and antioxidants in rats","volume":"16","author":"Liu","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.taap.2026.117796_bb0200","article-title":"Vitamin D3 mitigates lipopolysaccharide-induced oxidative stress, tight junction damage and intestinal inflammatory response in yellow catfish, Pelteobagrus fulvidraco","volume":"243","author":"Liu","year":"2021","journal-title":"Compar. Biochem. Physiol. Part C: Toxicol. Pharmacol."},{"issue":"2","key":"10.1016\/j.taap.2026.117796_bb0205","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.atherosclerosis.2012.08.037","article-title":"Effect of simvastatin or its combination with ezetimibe on toll-like receptor expression and lipopolysaccharide\u2013induced cytokine production in monocytes of hypercholesterolemic patients","volume":"225","author":"Moutzouri","year":"2012","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.taap.2026.117796_bb0210","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.phrs.2012.09.005","article-title":"Ezetimibe inhibits PMA-induced monocyte\/macrophage differentiation by altering microRNA expression: a novel anti-atherosclerotic mechanism","volume":"66","author":"Mu\u00f1oz-Pacheco","year":"2012","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.taap.2026.117796_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110388","article-title":"New possible pharmacological targets for statins and ezetimibe","volume":"129","author":"Niedzielski","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.taap.2026.117796_bb0220","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S1734-1140(13)71067-3","article-title":"LPS-induced oxidative stress and inflammatory reaction in the rat striatum","volume":"65","author":"Noworyta-Soko\u0142owska","year":"2013","journal-title":"Pharmacol. Rep."},{"issue":"2","key":"10.1016\/j.taap.2026.117796_bb0225","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.taap.2026.117796_bb0230","series-title":"Seminars in Immunopathology","article-title":"Innate and adaptive immunity in atherosclerosis","author":"Packard","year":"2009"},{"key":"10.1016\/j.taap.2026.117796_bb0235","first-page":"415","article-title":"Ezetimibe therapy: mechanism of action and clinical update","author":"Phan","year":"2012","journal-title":"Vasc. Health Risk Manag."},{"issue":"1\u20132","key":"10.1016\/j.taap.2026.117796_bb0240","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000357953","article-title":"Anti-inflammatory activity of ezetimibe by regulating NF-\u03baB\/MAPK pathway in THP-1 macrophages","volume":"93","author":"Qin","year":"2014","journal-title":"Pharmacology"},{"issue":"4","key":"10.1016\/j.taap.2026.117796_bb0245","doi-asserted-by":"crossref","DOI":"10.1615\/CritRevImmunol.2015015461","article-title":"Pathogenesis of multiple organ failure in sepsis","volume":"35","author":"Rossaint","year":"2015","journal-title":"Crit. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.taap.2026.117796_bb0250","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1203\/01.pdr.0000252437.51779.21","article-title":"Lipopolysaccharide exposure modifies high tidal volume ventilation-induced proinflammatory mediator expression in newborn rat lungs","volume":"61","author":"Roth-Kleiner","year":"2007","journal-title":"Pediatr. Res."},{"issue":"1","key":"10.1016\/j.taap.2026.117796_bb0255","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.atherosclerosis.2007.08.004","article-title":"Atherosclerotic lesion development and toll like receptor 2 and 4 responsiveness","volume":"197","author":"Schoneveld","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.taap.2026.117796_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2018.00026","article-title":"The consequences of preterm birth and chorioamnionitis on brainstem respiratory centers: implications for neurochemical development and altered functions by inflammation and prostaglandins","volume":"12","author":"Stojanovska","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"22","key":"10.1016\/j.taap.2026.117796_bb0265","doi-asserted-by":"crossref","first-page":"6949","DOI":"10.3390\/molecules26226949","article-title":"Quercetin prevents LPS-induced oxidative stress and inflammation by modulating NOX2\/ROS\/NF-kB in lung epithelial cells","volume":"26","author":"Sul","year":"2021","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.taap.2026.117796_bb0270","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1517\/17425255.3.3.441","article-title":"Ezetimibe: an update on the mechanism of action, pharmacokinetics and recent clinical trials","volume":"3","author":"Sweeney","year":"2007","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"10","key":"10.1016\/j.taap.2026.117796_bb0275","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.taap.2026.117796_bb0280","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11011-020-00629-9","article-title":"Amelioration of oxidative stress and neuroinflammation in lipopolysaccharide-induced memory impairment using Rosmarinic acid in mice","volume":"36","author":"Thingore","year":"2021","journal-title":"Metab. Brain Dis."},{"issue":"1","key":"10.1016\/j.taap.2026.117796_bb0285","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/jpp\/rgaa015","article-title":"Rutin prevents inflammation induced by lipopolysaccharide in RAW 264.7 cells via conquering the TLR4-MyD88-TRAF6-NF-\u03baB signalling pathway","volume":"73","author":"Tian","year":"2021","journal-title":"J. Pharm. Pharmacol."},{"issue":"11","key":"10.1016\/j.taap.2026.117796_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142430","article-title":"Ezetimibe attenuates atherosclerosis associated with lipid reduction and inflammation inhibition","volume":"10","author":"Tie","year":"2015","journal-title":"PLoS One"},{"issue":"01","key":"10.1016\/j.taap.2026.117796_bb0295","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1055\/s-2006-927397","article-title":"Cellular and cytokine-mediated mechanisms of inflammation and its modulation in immune-mediated liver injury","volume":"45","author":"Tiegs","year":"2007","journal-title":"Z. Gastroenterol."},{"issue":"5","key":"10.1016\/j.taap.2026.117796_bb0300","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1096\/fba.2018-00044","article-title":"Identification of hepatic NPC1L1 as an NAFLD risk factor evidenced by ezetimibe-mediated steatosis prevention and recovery","volume":"1","author":"Toyoda","year":"2019","journal-title":"FASEB BioAdv."},{"issue":"4","key":"10.1016\/j.taap.2026.117796_bb0305","doi-asserted-by":"crossref","first-page":"817","DOI":"10.5114\/aoms.2013.38087","article-title":"Experimental research influence of ezetimibe on selected parameters of oxidative stress in rat liver subjected to ischemia\/reperfusion","volume":"10","author":"Trocha","year":"2014","journal-title":"Arch. Med. Sci."},{"issue":"5","key":"10.1016\/j.taap.2026.117796_bb0310","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.hlc.2015.10.012","article-title":"Effects of combination of ezetimibe and rosuvastatin on coronary artery plaque in patients with coronary heart disease","volume":"25","author":"Wang","year":"2016","journal-title":"Heart Lung Circul."},{"issue":"5","key":"10.1016\/j.taap.2026.117796_bb0315","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11050914","article-title":"The inhibition of LPS-induced oxidative stress and inflammatory responses is associated with the protective effect of (\u2212)-Epigallocatechin-3-Gallate on bovine hepatocytes and murine liver","volume":"11","author":"Xu","year":"2022","journal-title":"Antioxidants"},{"issue":"8","key":"10.1016\/j.taap.2026.117796_bb0320","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.burns.2023.06.005","article-title":"Lipopolysaccharide induces skin scarring through the TLR4\/Myd88 inflammatory signaling pathway in dermal fibroblasts","volume":"49","author":"Xu","year":"2023","journal-title":"Burns"},{"issue":"1","key":"10.1016\/j.taap.2026.117796_bb0325","article-title":"Ezetimibe attenuates oxidative stress and neuroinflammation via the AMPK\/Nrf2\/TXNIP pathway after MCAO in rats","volume":"2020","author":"Yu","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"4","key":"10.1016\/j.taap.2026.117796_bb0330","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/mco2.104","article-title":"NF-\u03baB signaling in inflammation and cancer","volume":"2","author":"Zhang","year":"2021","journal-title":"MedComm"},{"issue":"1","key":"10.1016\/j.taap.2026.117796_bb0335","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/advances\/nmy076","article-title":"Potential of omega-3 polyunsaturated fatty acids in managing chemotherapy-or radiotherapy-related intestinal microbial dysbiosis","volume":"10","author":"Zhang","year":"2019","journal-title":"Adv. Nutr."},{"issue":"3","key":"10.1016\/j.taap.2026.117796_bb0340","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032112","article-title":"Deficiency of S100A9 alleviates sepsis-induced acute liver injury through regulating AKT-AMPK-dependent mitochondrial energy metabolism","volume":"24","author":"Zhang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.taap.2026.117796_bb0345","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejphar.2008.01.045","article-title":"Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice","volume":"584","author":"Zheng","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2026.117796_bb0350","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.biopha.2018.10.201","article-title":"Icariside II attenuates lipopolysaccharide-induced neuroinflammation through inhibiting TLR4\/MyD88\/NF-\u03baB pathway in rats","volume":"111","author":"Zhou","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.taap.2026.117796_bb0355","doi-asserted-by":"crossref","DOI":"10.3390\/nu15061517","article-title":"Anti-inflammatory effects of lipid-lowering drugs and supplements\u2014a narrative review","volume":"15","author":"Zivkovic","year":"2023","journal-title":"Nutrients"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X2600092X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X2600092X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T13:14:43Z","timestamp":1784812483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X2600092X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":71,"alternative-id":["S0041008X2600092X"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2026.117796","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ezetimibe counteracts lipopolysaccharide-induced liver injury in mice via modulating TLR4-mediated MYD88\/TRAF-6\/NF-kB signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2026.117796","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117796"}}